Tuesday, June 23, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 635 of 1,261
  1. US 9644018

    Antibody modulators of APLNR

    REGENERON PHARMACEUTICALS, INC. · Granted May 9, 2017 · Expires May 4, 2037

    granted
  2. WO 2017072335

    UTILISATION DE MASITINIB ET D'AUTRES INHIBITEURS DE MASTOCYTE POUR LE TRAITEMENT DE LA MALADIE DE PARKINSON

    AB SCIENCE [FR] · Granted May 4, 2017 · Expires Apr 29, 2037

    granted
  3. US 2017119760

    USE OF MASITINIB FOR THE TREATMENT OF PROGRESSIVE SUPRANUCLEAR PALSY

    AB SCIENCE [FR] · Granted May 4, 2017 · Expires Apr 29, 2037

    granted
  4. US 9636305

    Antiemetic extended release solid dosage forms

    RedHill Biopharma Ltd. · Granted May 2, 2017 · Expires Apr 27, 2037

    granted
  5. US 9636412

    Conjugates of an anti-TNF-alpha antibody

    Nektar Therapeutics · Granted May 2, 2017 · Expires Apr 27, 2037

    granted
  6. US 9637524

    Proteolysis-resistant capsid of chimeric hepatitis E virus as an oral delivery vector

    The Regents of the University of California · Granted May 2, 2017 · Expires Apr 27, 2037

    granted
  7. US 9636374

    pH-sensitive polymer-drug conjugates for targeted delivery of therapeutics

    Northwestern University · Granted May 2, 2017 · Expires Apr 27, 2037

    granted
  8. US 9636406

    Method of treating cancer

    Intensity Therapeutics, Inc. · Granted May 2, 2017 · Expires Apr 27, 2037

    granted
  9. US 9636416

    Immunoglobulin chimeric monomer-dimer hybrids

    BIOVERATIV THERAPEUTICS INC. · Granted May 2, 2017 · Expires Apr 27, 2037

    granted
  10. US 9637483

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted May 2, 2017 · Expires Apr 27, 2037

    granted
  11. US 9636408

    Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride

    TONIX PHARMA LIMITED · Granted May 2, 2017 · Expires Apr 27, 2037

    granted
  12. US 9636649

    Dispersions comprising discrete carbon nanotube fibers

    MOLECULAR REBAR DESIGN, LLC · Granted May 2, 2017 · Expires Apr 27, 2037

    granted
  13. US 9636329

    Methods of treating cancer with glut inhibitors and oxidative phosphorylation inhibitors

    Northwestern University · Granted May 2, 2017 · Expires Apr 27, 2037

    granted
  14. US 9636334

    Combination of lenalidomide and polypeptide construct, and uses thereof

    TEVA PHARMACEUTICALS AUSTRALIA PTY LTD · Granted May 2, 2017 · Expires Apr 27, 2037

    granted
  15. US 9639665

    Methods for diagnosis and intervention of hepatic disorders

    The Regents of the University of Colorado, a Body Corporate · Granted May 2, 2017 · Expires Apr 27, 2037

    granted
  16. US 9638639

    Plasmonic-magnetic bifunctional nanotubes for biological applications

    The Board of Regents of the University of Texas System · Granted May 2, 2017 · Expires Apr 27, 2037

    granted
  17. US 9637738

    Methods and agents to increase therapeutic dystrophin expression in muscle

    ReveraGen BioPharma, Inc. · Granted May 2, 2017 · Expires Apr 27, 2037

    granted
  18. US 9636301

    In vitro release assay for liposome encapsulated vincristine

    ARBUTUS BIOPHARMA CORPORATION · Granted May 2, 2017 · Expires Apr 27, 2037

    granted
  19. US 9637597

    DOPA-melanin formation in high ionic strength solutions

    Northwestern University · Granted May 2, 2017 · Expires Apr 27, 2037

    granted
  20. US 9637535

    IL-33 antagonists and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted May 2, 2017 · Expires Apr 27, 2037

    granted
  21. US 9637519

    Peptide for inducing mast cell-specific apoptosis and use thereof

    CAREGEN CO., LTD. · Granted May 2, 2017 · Expires Apr 27, 2037

    granted
  22. US 9636515

    Method of repairing age and disease immune dysfunction and cellular senescence with lymphoid stem cells and then re-applying those for therapeutic use

    Advanced Neuroregenerative Therapies, LLC. · Granted May 2, 2017 · Expires Apr 27, 2037

    granted
  23. US 9636424

    Composition, method, system and kit for optical electrophysiology

    UNIVERSITY OF CONNECTICUT · Granted May 2, 2017 · Expires Apr 27, 2037

    granted
  24. US 9636400

    VEGF specific fusion protein antagonist formulations

    REGENERON PHARMACEUTICALS, INC. · Granted May 2, 2017 · Expires Apr 27, 2037

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.